Ovarian Cancer
Showing NaN - NaN of 106
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)
Active, not recruiting
- Ovarian Cancer
- +4 more
- DPX-Survivac
- +2 more
-
Tucson, Arizona
- +22 more
Mar 28, 2022
Ovarian Cancer Trial in Los Angeles (Pembrolizumab, Gemcitabine, Cisplatin)
Completed
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 14, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)
Completed
- Breast Cancer
- +3 more
- FPA150
- Pembrolizumab
-
Scottsdale, Arizona
- +17 more
Jan 6, 2022
Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)
Completed
- Ovarian Neoplasms
- Ovarian Cancer
-
Chandler, Arizona
- +54 more
Sep 24, 2021
Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)
Completed
- Tumor
- Ovarian Cancer
- NKTR-102 q14d
- NKTR-102 q21d
-
Highland, California
- +19 more
Jul 9, 2021
Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)
Completed
- Brain Tumor
- +8 more
- sodium thiosulfate
- examination
-
Birmingham, Alabama
- +75 more
Jul 1, 2021
Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine
Recruiting
- Small-cell Lung Cancer
- +4 more
- Tinostamustine (EDO-S101)
-
Los Angeles, California
- +7 more
Dec 22, 2020
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)
Completed
- Ovarian Cancer
- +2 more
- EPO906 (Patupilone)
- doxorubicin
-
Anchorage, Alaska
- +148 more
Dec 11, 2020
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and
Completed
- Cervical Cancer
- +16 more
- INCAGN02385
-
Los Angeles, California
- +3 more
Oct 28, 2020
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,
Completed
- Epithelial Ovarian Cancer
- +3 more
- Mirvetuximab soravtansine
- +3 more
-
Birmingham, Alabama
- +130 more
Sep 24, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Ovarian Cancer Trial in United States (Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD), Topotecan)
Completed
- Ovarian Cancer
- Lurbinectedin (PM01183)
- +2 more
-
Peoria, Arizona
- +27 more
Mar 25, 2020